Publications

Publications published since 2000 from OUS - Department of Nephrology (Div Med)

336 publications found

Publications 2024

1. Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
   Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
   High Blood Press Cardiovasc Prev (in press)
   DOI 10.1007/s40292-024-00632-6, PubMed 38530572
2. Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD (2024)
   Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage
   Blood Press, 33 (1), 2323980
   DOI 10.1080/08037051.2024.2323980, PubMed 38606688
3. Brobak KM, Melsom T, Eriksen BO, Høieggen A, Norvik JV, Solbu MD (2024)
   The association between urinary sodium-potassium ratio, kidney function, and blood pressure in a cohort from the general population
   Kidney Blood Press Res (in press)
   DOI 10.1159/000535977, PubMed 38382490
4. Fadl Elmula FEM, Mariampillai JE, Heimark S, Kjeldsen SE, Burnier M (2024)
   Medical Measures in Hypertensives Considered Resistant
   Am J Hypertens, 37 (5), 307-317
   DOI 10.1093/ajh/hpad118, PubMed 38124494
5. Kjeldsen SE, Egan BM, Burnier M, Narkiewicz K, Kreutz R, Mancia G (2024)
   Highlights of the 2023 European Society of Hypertension Guidelines: what has changed in the management of hypertension in patients with cardiac diseases?
   Blood Press, 33 (1), 2329571
   DOI 10.1080/08037051.2024.2329571, PubMed 38555859
6. Mancia G, Brunström M, Burnier M, Grassi G, Januszewicz A, Kjeldsen SE, Muiesan ML, Thomopoulos C, Tsioufis K, Kreutz R (2024)
   Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
   Hypertension, 81 (5), 1021-1030
   DOI 10.1161/HYPERTENSIONAHA.124.22821, PubMed 38477109
7. Mancia G, Brunström M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Kjeldsen SE, Kreutz R (2024)
   Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
   Eur J Intern Med, 121, 4-8
   DOI 10.1016/j.ejim.2023.12.015, PubMed 38216445
8. Sevre K, Rist A, Wachtell K, Devereux RB, Aurigemma GP, Smiseth OA, Kjeldsen SE, Julius S, Pitt B, Burnier M, Kreutz R, Oparil S, Mancia G, Zannad F (2024)
   What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
   Am J Hypertens, 37 (1), 1-14
   DOI 10.1093/ajh/hpad073, PubMed 37551929
9. Sharif A, Chakkera H, de Vries APJ, Eller K, Guthoff M, Haller MC, Hornum M, Nordheim E, Kautzky-Willer A, Krebs M, Kukla A, Kurnikowski A, Schwaiger E, Montero N, Pascual J, Jenssen TG, Porrini E, Hecking M (2024)
   International consensus on post-transplantation diabetes mellitus
   Nephrol Dial Transplant, 39 (3), 531-549
   DOI 10.1093/ndt/gfad258, PubMed 38171510

Publications 2023

1. Bjerre A, Aase SA, Radtke M, Siva C, Gudmundsdottir H, Forsberg B, Woldseth B, Brackman D (2023)
   The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study
   Pediatr Nephrol, 38 (11), 3671-3679
   DOI 10.1007/s00467-023-06005-w, PubMed 37219641
2. Blom KB, Birkeland GK, Midtvedt K, Jenssen TG, Reisæter AV, Rollag H, Hartmann A, Sagedal S, Sjaastad I, Tylden G, Njølstad G, Nilsen E, Christensen A, Åsberg A, Birkeland JA (2023)
   Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
   Transplantation, 107 (8), 1846-1853
   DOI 10.1097/TP.0000000000004615, PubMed 37211633
3. Burnier M, Brguljan J, Algharably EAE, Kjeldsen SE, Narkiewicz K, Egan B, Oparil S, Kreutz R (2023)
   Women's health, cardiovascular risk and hypertension: the perspective still needs to improve
   Blood Press, 32 (1), 2193648
   DOI 10.1080/08037051.2023.2193648, PubMed 37066492
4. Burnier M, Narkiewicz K, Kjeldsen SE (2023)
   How to optimize the use of diuretics in patients with heart failure?
   Kardiol Pol, 81 (10), 944-949
   DOI 10.33963/v.kp.97315, PubMed 37718589
5. Feinberg JB, Nielsen EE, Kjeldsen SE, Devereux RB, Gerdts E, Wachtell K, Olsen MH (2023)
   Sex Differences in Atrial Fibrillation and Associated Complications in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study
   Am J Hypertens, 36 (10), 536-541
   DOI 10.1093/ajh/hpad057, PubMed 37382177
6. Heimark S, Bøtker-Rasmussen KG, Stepanov A, Haga ØG, Gonzalez V, Seeberg TM, Fadl Elmula FEM, Waldum-Grevbo B (2023)
   Accuracy of non-invasive cuffless blood pressure in the intensive care unit: Promises and challenges
   Front Med (Lausanne), 10, 1154041
   DOI 10.3389/fmed.2023.1154041, PubMed 37138759
7. Heimark S, Hove C, Stepanov A, Boysen ES, Gløersen Ø, Bøtke-Rasmussen KG, Gravdal HJ, Narayanapillai K, Fadl Elmula FEM, Seeberg TM, Larstorp ACK, Waldum-Grevbo B (2023)
   Accuracy and User Acceptability of 24-hour Ambulatory Blood Pressure Monitoring by a Prototype Cuffless Multi-Sensor Device Compared to a Conventional Oscillometric Device
   Blood Press, 32 (1), 2274595
   DOI 10.1080/08037051.2023.2274595, PubMed 37885101
8. Heimark S, Mehlum MH, Mancia G, Søraas CL, Liestøl K, Wachtell K, Larstorp AC, Rostrup M, Mariampillai JE, Kjeldsen SE, Julius S, Weber MA (2023)
   Middle-Aged and Older Patients With Left Ventricular Hypertrophy: Higher Mortality With Drug Treated Systolic Blood Pressure Below 130 mm Hg
   Hypertension, 80 (8), 1739-1748
   DOI 10.1161/HYPERTENSIONAHA.123.21454, PubMed 37350267
9. Kjeldsen SE, Burnier M, Narkiewicz K, Kreutz R, Mancia G (2023)
   Key questions regarding the SYMPLICITY HTN-3 trial
   Lancet, 401 (10385), 1336-1337
   DOI 10.1016/S0140-6736(23)00340-9, PubMed 37087164
10. Kjeldsen SE, Egan BM, Narkiewicz K, Kreutz R, Burnier M, Oparil S, Mancia G (2023)
    TIME to face the reality about evening dosing of antihypertensive drugs in hypertension
    Blood Press, 32 (1), 1-3
    DOI 10.1080/08037051.2022.2142512, PubMed 36369908
11. Kjeldsen SE, Mariampillai JE, Høieggen A (2023)
    Uric acid and left ventricular mass in prediction of cardiovascular risk-New insight from the URRAH study
    Eur J Intern Med, 114, 45-46
    DOI 10.1016/j.ejim.2023.05.016, PubMed 37179137
12. Ljungman S, Jensen JE, Paulsen D, Petersons A, Ots-Rosenberg M, Saha H, Struijk D, Wilkie M, Heimbürger O, Stegmayr B, Elung-Jensen T, Johansson AC, Rydström M, Gudmundsdottir H, Hussain-Alkhateeb L, Peritonitis Prevention Study (PEPS) Trial Investigators (2023)
    Factors associated with time to first dialysis-associated peritonitis episode: Data from the Peritonitis Prevention Study (PEPS)
    Perit Dial Int, 43 (3), 241-251
    DOI 10.1177/08968608231161179, PubMed 37021365
13. Malho Guedes A, Punzalan S, Brown EA, Ekstrand A, Gallieni M, Rivera Gorrín M, Gudmundsdottir H, Heidempergher M, Kitsche B, Lobbedez T, Hahn Lundström U, McCarthy K, Mellotte GJ, Moranne O, Petras D, Povlsen JV, Wiesholzer M (2023)
    Assisted PD throughout Europe: advantages, inequities, and solution proposals
    J Nephrol, 36 (9), 2549-2557
    DOI 10.1007/s40620-023-01765-y, PubMed 37856067
14. Mancia G, Kjeldsen SE (2023)
    Randomized Clinical Outcome Trials in Hypertension
    Hypertension, 81 (1), 17-23
    DOI 10.1161/HYPERTENSIONAHA.123.21725, PubMed 37795644
15. Mariampillai JE, Halvorsen LV, Larstorp AC, Heimark S, Waldum-Grevbo B, Kjeldsen SE, Nordby G, Stenehjem AE, Berg JP, Høieggen A (2023)
    [Not Available]
    Tidsskr Nor Laegeforen, 143 (12)
    DOI 10.4045/tidsskr.22.0822, PubMed 37668137
16. Persu A, Stoenoiu MS, Maes F, Kreutz R, Mancia G, Kjeldsen SE (2023)
    Late outcomes of renal denervation are more favourable than early ones: facts or fancies?
    Clin Kidney J, 16 (12), 2357-2364
    DOI 10.1093/ckj/sfad231, PubMed 38046011

Publications 2022

1. Brobak KM, Andreassen RM, Melsom T, Høieggen A, Norvik JV, Solbu MD (2022)
   Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension after 7 years. The Tromsø Study
   Blood Press, 31 (1), 270-283
   DOI 10.1080/08037051.2022.2128043, PubMed 36193001
2. Brown EA, Ekstrand A, Gallieni M, Gorrín MR, Gudmundsdottir H, Guedes AM, Heidempergher M, Kitsche B, Lobbedez T, Lundström UH, McCarthy K, Mellotte GJ, Moranne O, Petras D, Povlsen JV, Punzalan S, Wiesholzer M (2022)
   Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
   Nephrol Dial Transplant, 37 (11), 2080-2089
   DOI 10.1093/ndt/gfac193, PubMed 35671088
3. Burnier M, Kjeldsen SE (2022)
   A 30th anniversary and a glimpse of the future
   Blood Press, 31 (1), 1-3
   DOI 10.1080/08037051.2021.2021638, PubMed 35060412
4. Burnier M, Kjeldsen SE, Narkiewicz K, Egan B, Kreutz R (2022)
   Hypertension management during the COVID-19 pandemic: what can we learn for the future?
   Blood Press, 31 (1), 47-49
   DOI 10.1080/08037051.2022.2058909, PubMed 35426323
5. Chan J, Svensson M, Tannæs TM, Waldum-Grevbo B, Jenssen T, Eide IA (2022)
   Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation
   Am J Nephrol, 53 (2-3), 108-117
   DOI 10.1159/000521757, PubMed 35104815
6. Egan BM, Kjeldsen SE, Narkiewicz K, Kreutz R, Burnier M (2022)
   Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions
   Blood Press, 31 (1), 164-168
   DOI 10.1080/08037051.2022.2095254, PubMed 35876172
7. Engvig A, Maglanoc LA, Doan NT, Westlye LT, Alzheimer’s Disease Neuroimaging Initiative (2022)
   Data-driven health deficit assessment improves a frailty index's prediction of current cognitive status and future conversion to dementia: results from ADNI
   Geroscience, 45 (1), 591-611
   DOI 10.1007/s11357-022-00669-2, PubMed 36260263
8. Halvorsen LV, Bergland OU, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Kringen MK, Clasen PE, Haldsrud R, Kjeldsen SE, Rostrup M, Fadl Elmula FEM, Opdal MS, Høieggen A (2022)
   Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7-Year Follow-Up of Patients Considered Adherent by Directly Observed Therapy
   J Am Heart Assoc, 11 (18), e025879
   DOI 10.1161/JAHA.121.025879, PubMed 36073648
9. Kjeldsen SE, Egan BM, Narkiewicz K, Kreutz R, Burnier M, Oparil S (2022)
   Thirty years with LIFE-a randomized clinical trial with more than 200 published articles on clinical aspects of left ventricular hypertrophy
   Blood Press, 31 (1), 125-128
   DOI 10.1080/08037051.2022.2083578, PubMed 35674494
10. Kolskår KK, Ulrichsen KM, Richard G, Dørum ES, de Schotten MT, Rokicki J, Monereo-Sánchez J, Engvig A, Hansen HI, Nordvik JE, Westlye LT, Alnaes D (2022)
    Structural disconnectome mapping of cognitive function in poststroke patients
    Brain Behav, 12 (8), e2707
    DOI 10.1002/brb3.2707, PubMed 35861657
11. Narkiewicz K, Kjeldsen SE, Egan BM, Kreutz R, Burnier M (2022)
    Masked hypertension in type 2 diabetes: never take normotension for granted and always assess out-of-office blood pressure
    Blood Press, 31 (1), 207-209
    DOI 10.1080/08037051.2022.2107483, PubMed 35941816
12. Thorstensen CW, Clasen PE, Rognstad S, Haldsrud R, Føreid S, Helstrøm T, Bergland OU, Halvorsen LV, Aune A, Olsen E, Brobak KM, Høieggen A, Gustavsen I, Larstorp ACK, Søraas CL, Opdal MS (2022)
    Development of UHPLC-MS/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension
    J Pharm Biomed Anal, 219, 114908
    DOI 10.1016/j.jpba.2022.114908, PubMed 35803015
13. Tsarpali V, Midtvedt K, Lønning K, Bernklev T, Åsberg A, Fawad H, von der Lippe N, Reisæter AV, Røysland K, Heldal K (2022)
    A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
    Transplant Direct, 8 (4), e1307
    DOI 10.1097/TXD.0000000000001307, PubMed 35350108
14. Tsarpali V, Midtvedt K, Lønning K, Bernklev T, Åsberg A, von der Lippe N, Reisæter AV, Heldal K (2022)
    Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
    Transplant Direct, 8 (11), e1374
    DOI 10.1097/TXD.0000000000001374, PubMed 36245999

Publications 2021

1. Andersen MH, Urstad KH, Larsen MH, Henrichsen GF, Engebretsen E, Ødemark J, Stenehjem AE, Reisaeter AV, Nordlie A, Wahl AK (2021)
   Intervening on health literacy by knowledge translation processes in kidney transplantation: A feasibility study
   J Ren Care, 48 (1), 60-68
   DOI 10.1111/jorc.12379, PubMed 34053202
2. Bergland OU, Halvorsen LV, Søraas CL, Hjørnholm U, Kjær VN, Rognstad S, Brobak KM, Aune A, Olsen E, Fauchald YM, Heimark S, Thorstensen CW, Liestøl K, Solbu MD, Gerdts E, Mo R, Rostrup M, Kjeldsen SE, Høieggen A, Opdal MS, Larstorp ACK, Fadl Elmula FEM (2021)
   Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations
   Hypertension, 78 (3), 617-628
   DOI 10.1161/HYPERTENSIONAHA.121.17514, PubMed 34275336
3. Blom KB, Åsberg A, Sjaastad I, Kalleberg KT, Søraas A, Midtvedt K, Birkeland JA (2021)
   Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
   Kidney Med, 4 (2), 100389
   DOI 10.1016/j.xkme.2021.09.006, PubMed 34805967
4. Burnier M, Kjeldsen SE, Narkiewicz K, Oparil S (2021)
   Cuff-less measurements of blood pressure: are we ready for a change?
   Blood Press, 30 (4), 205-207
   DOI 10.1080/08037051.2021.1956178, PubMed 34308727
5. Chan J, Eide IA, Tannæs TM, Waldum-Grevbo B, Jenssen T, Svensson M (2021)
   Marine n-3 Polyunsaturated Fatty Acids and Cellular Senescence Markers in Incident Kidney Transplant Recipients: The Omega-3 Fatty Acids in Renal Transplantation (ORENTRA) Randomized Clinical Trial
   Kidney Med, 3 (6), 1041-1049
   DOI 10.1016/j.xkme.2021.07.010, PubMed 34939013
6. Engvig A, Wyller TB, Skovlund E, Ahmed MV, Hall TS, Rockwood K, Njaastad AM, Neerland BE (2021)
   Association between clinical frailty, illness severity and post-discharge survival: a prospective cohort study of older medical inpatients in Norway
   Eur Geriatr Med, 13 (2), 453-461
   DOI 10.1007/s41999-021-00555-8, PubMed 34417977
7. Falk RS, Mariampillai JE, Prestgaard EE, Heir T, Bodegård J, Robsahm TE, Grundvold I, Skretteberg PT, Engeseth K, Bjornholt JV, Stavem K, Liestøl K, Sandvik L, Thaulow E, Erikssen G, Kjeldsen SE, Gjesdal K, Erikssen JE (2021)
   The Oslo Ischaemia Study: cohort profile
   BMJ Open, 11 (10), e049111
   DOI 10.1136/bmjopen-2021-049111, PubMed 34645662
8. Hahn Lundström U, Abrahams AC, Allen J, Altabas K, Béchade C, Burkhalter F, Clause AL, Corbett RW, Eden G, François K, de Laforcade L, Lambie M, Martin H, Pajek J, Panuccio V, Ros-Ruiz S, Steubl D, Vega A, Wojtaszek E, Zaloszyc A, Davies SJ, Van Biesen W, Gudmundsdottir H (2021)
   Barriers and opportunities to increase PD incidence and prevalence: Lessons from a European Survey
   Perit Dial Int, 41 (6), 542-551
   DOI 10.1177/08968608211034988, PubMed 34409901
9. Kasiakogias A, Rosei EA, Camafort M, Ehret G, Faconti L, Ferreira JP, Brguljan J, Januszewicz A, Kahan T, Manolis A, Tsioufis K, Weber T, von Lueder TG, Smiseth OA, Wachtell K, Kjeldsen SE, Zannad F, Mancia G, Kreutz R (2021)
   Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
   J Hypertens, 39 (8), 1522-1545
   DOI 10.1097/HJH.0000000000002910, PubMed 34102660
10. Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2021)
    Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes - from single pill combinations to monitoring of a nationwide health insurance database
    Blood Press, 30 (3), 143-144
    DOI 10.1080/08037051.2021.1917192, PubMed 33910432
11. Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2021)
    The five RADIANCE-HTN and SPYRAL-HTN randomised studies suggest that the BP lowering effect of RDN corresponds to the effect of one antihypertensive drug
    Blood Press, 30 (6), 327-331
    DOI 10.1080/08037051.2021.1995975, PubMed 34714185
12. Kreutz R, Cífková R, Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S, Mancia G (2021)
    In Memoriam: Jiří Widimský Sr. 1925-2020
    J Hypertens, 39 (2), 386-388
    DOI 10.1097/HJH.0000000000002768, PubMed 37696754
13. Kreutz R, Kjeldsen SE, Mancia G (2021)
    Why we do not need a single independent international hypertension clinical practice guideline
    J Hypertens, 39 (11), 2125-2127
    DOI 10.1097/HJH.0000000000002940, PubMed 34224539
14. Midtvedt K, Tran T, Parker K, Marti HP, Stenehjem AE, Gøransson LG, Mørkve Soldal K, Madsen C, Smedbråten J, Vaage EB, Lund-Johansen F, Åsberg A (2021)
    Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
    Transplantation, 105 (8), e80-e81
    DOI 10.1097/TP.0000000000003856, PubMed 34132229
15. Narkiewicz K, Burnier M, Kjeldsen SE, Oparil S (2021)
    Combining proteomics, home blood pressure telemonitoring and patient empowerment to improve cardiovascular and renal protection
    Blood Press, 30 (5), 267-268
    DOI 10.1080/08037051.2021.1975878, PubMed 34586009
16. Olsen E, Holzhauer B, Julius S, Kjeldsen SE, Larstorp ACK, Mancia G, Mehlum MH, Mo R, Rostrup M, Søraas CL, Zappe D, Weber MA (2021)
    Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk
    Blood Press, 30 (2), 90-97
    DOI 10.1080/08037051.2020.1856642, PubMed 33403890
17. Onsøien MO, Midtvedt K, Reisæter AV, Aasarød K, Waldum-Grevbo B, Vikse BE, Eriksen BO, Åsberg A (2021)
    Blood Pressure Treatment in Kidney Transplant Recipients-Can We Improve?
    Transplant Direct, 7 (4), e688
    DOI 10.1097/TXD.0000000000001142, PubMed 33786373
18. Rognstad S, Søraas CL, Bergland OU, Høieggen A, Strømmen M, Helland A, Opdal MS (2021)
    Establishing Serum Reference Ranges for Antihypertensive Drugs
    Ther Drug Monit, 43 (1), 116-125
    DOI 10.1097/FTD.0000000000000806, PubMed 32881780
19. Ulrichsen KM, Kolskår KK, Richard G, Alnæs D, Dørum ES, Sanders AM, Tornås S, Sánchez JM, Engvig A, Ihle-Hansen H, de Schotten MT, Nordvik JE, Westlye LT (2021)
    Structural brain disconnectivity mapping of post-stroke fatigue
    Neuroimage Clin, 30, 102635
    DOI 10.1016/j.nicl.2021.102635, PubMed 33799271
20. Undrum Bergland O, Larstorp ACK, Lund Søraas C, Høieggen A, Rostrup M, Norheim Kjaer V, Godang K, Sevre K, Fadl Elmula FEM (2021)
    Changes in sympathetic nervous system activity after renal denervation: results from the randomised Oslo RDN study
    Blood Press, 30 (3), 154-164
    DOI 10.1080/08037051.2020.1868286, PubMed 33399016
21. van Eck van der Sluijs A, van Jaarsveld BC, Allen J, Altabas K, Béchade C, Bonenkamp AA, Burkhalter F, Clause AL, Corbett RW, Dekker FW, Eden G, François K, Gudmundsdottir H, Lundström UH, de Laforcade L, Lambie M, Martin H, Pajek J, Panuccio V, Ros-Ruiz S, Steubl D, Vega A, Wojtaszek E, Davies SJ, Van Biesen W et al. (2021)
    Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availability
    Perit Dial Int, 41 (6), 533-541
    DOI 10.1177/08968608211049882, PubMed 34672219
22. Varsi C, Stenehjem AE, Børøsund E, Solberg Nes L (2021)
    Video as an alternative to in-person consultations in outpatient renal transplant recipient follow-up: a qualitative study
    BMC Nephrol, 22 (1), 105
    DOI 10.1186/s12882-021-02284-3, PubMed 33752608

Publications 2020

1. Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM (2020)
   The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up
   Blood Press, 30 (1), 41-50
   DOI 10.1080/08037051.2020.1828818, PubMed 33030064
2. Bergo KK, Larstorp AC, Hoffmann P, Hjørnholm U, Cataliotti A, Høieggen A, Rostrup M, Fadl Elmula FEM (2020)
   Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
   Blood Press, 30 (1), 31-40
   DOI 10.1080/08037051.2020.1789446, PubMed 32633141
3. Boenink R, Stel VS, Waldum-Grevbo BE, Collart F, Kerschbaum J, Heaf JG, de Meester J, Finne P, García-Marcos SA, Evans M, Ambühl PM, Arici M, Ayav C, Steenkamp R, Cases A, Traynor JP, Palsson R, Zoccali C, Massy ZA, Jager KJ, Kramer A (2020)
   Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy
   Kidney Int, 98 (4), 999-1008
   DOI 10.1016/j.kint.2020.05.039, PubMed 32569654
4. Folkestad T, Brurberg KG, Nordhuus KM, Tveiten CK, Guttormsen AB, Os I, Beitland S (2020)
   Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis
   Crit Care, 24 (1), 2
   DOI 10.1186/s13054-019-2710-4, PubMed 31898523
5. Jansz TT, Noordzij M, Kramer A, Laruelle E, Couchoud C, Collart F, Cases A, Arici M, Helve J, Waldum-Grevbo B, Rydell H, Traynor JP, Zoccali C, Massy ZA, Jager KJ, van Jaarsveld BC (2020)
   Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry
   Nephrol Dial Transplant, 35 (3), 488-495
   DOI 10.1093/ndt/gfz208, PubMed 31740955
6. Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
   Was it optimal to drop a diuretic as a first-line choice of drug treatment in the 2020 International Society of Hypertension Guidelines?
   Blood Press, 29 (6), 341-343
   DOI 10.1080/08037051.2020.1838766, PubMed 33140684
7. Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S (2020)
   Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
   Blood Press, 30 (1), 1-3
   DOI 10.1080/08037051.2021.1862483, PubMed 33349063
8. Kjeldsen SE, Os I (2020)
   Poor reproducibility of masked and white coat uncontrolled hypertension: important new information on MUCH and WUCH
   Eur Heart J, 41 (16), 1572-1574
   DOI 10.1093/eurheartj/ehz703, PubMed 31580419
9. Kjeldsen SE, Os I (2020)
   Assessing hypertension therapies: randomization or confounding by indication?
   Nat Rev Cardiol, 17 (2), 73-74
   DOI 10.1038/s41569-019-0313-z, PubMed 31768007
10. Kreutz R, Cífková R, Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S, Mancia G (2020)
    In memoriam: Jiří Widimský Sr. 1925-2020
    Blood Press, 30 (2), 140-142
    DOI 10.1080/08037051.2020.1859212, PubMed 33342305
11. Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
    In memoriam: Peter Sleight 1929-2020
    Blood Press, 29 (6), 382-384
    DOI 10.1080/08037051.2020.1839224, PubMed 33153320
12. Kreutz R, Kjeldsen SE, Burnier M, Narkiewicz K, Oparil S, Mancia G (2020)
    In memoriam: Peter Sleight 1929-2020
    J. Hypertens., 38 (12), 2546-2548
    DOI 10.1097/HJH.0000000000002713
13. Ljungman S, Jensen JE, Paulsen D, Petersons A, Ots-Rosenberg M, Saha H, Struijk DG, Wilkie M, Heimbürger O, Stegmayr B, Elung-Jensen T, Johansson AC, Rydström M, Gudmundsdottir H, Petzold M, Peritonitis Prevention Study (PEPS) Trial Investigators (2020)
    Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial
    Perit Dial Int, 40 (2), 141-152
    DOI 10.1177/0896860819887626, PubMed 32063220
14. Seljelid B, Varsi C, Solberg Nes L, Stenehjem AE, Bollerslev J, Børøsund E (2020)
    Content and system development of a digital patient-provider communication tool to support shared decision making in chronic health care: InvolveMe
    BMC Med Inform Decis Mak, 20 (1), 46
    DOI 10.1186/s12911-020-1065-8, PubMed 32131808
15. Thorsteinsdottir H, Salvador CL, Mjøen G, Lie A, Sugulle M, Tøndel C, Brun A, Almaas R, Bjerre A (2020)
    Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation
    Dis Markers, 2020, 6162892
    DOI 10.1155/2020/6162892, PubMed 32089755

Publications 2019

1. Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
   Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
   Blood Press, 29 (2), 123-134
   DOI 10.1080/08037051.2019.1684817, PubMed 31718316
2. Drangsholt SH, Cappelen UW, von der Lippe N, Høieggen A, Os I, Brekke FB (2019)
   Beliefs about medicines in dialysis patients and after renal transplantation
   Hemodial Int, 23 (1), 117-125
   DOI 10.1111/hdi.12717, PubMed 30714322
3. Hjørnholm U, Larstorp ACK, Andersen MH, Høieggen A (2019)
   Directly observed therapy prior to ambulatory blood pressure measurement (DOT-HTN) in uncontrolled hypertensive patients - Effect on blood pressure, safety and patient perception
   Blood Press, 28 (5), 327-335
   DOI 10.1080/08037051.2019.1633907, PubMed 31250668
4. Kjeldsen SE, Os I (2019)
   Are People With Masked Hypertension Adherent to Their Antihypertensive Medication?
   Hypertension, 74 (3), 497-498
   DOI 10.1161/HYPERTENSIONAHA.119.13350, PubMed 31327260
5. Kjeldsen SE, Os I, Westheim A (2019)
   Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
   J Hypertens, 37 (5), 902-904
   DOI 10.1097/HJH.0000000000002018, PubMed 30920495
6. Mjoen G, Abramowicz D (2019)
   What happens to the live donor in the years following donation?
   Nephrol. Dial. Transplant., 34 (8), 1289-1291
   DOI 10.1093/ndt/gfy356
7. Nilsson BB, Bunæs-Næss H, Edvardsen E, Stenehjem AE (2019)
   High-intensity interval training in haemodialysis patients: a pilot randomised controlled trial
   BMJ Open Sport Exerc Med, 5 (1), e000617
   DOI 10.1136/bmjsem-2019-000617, PubMed 31798950
8. Parker K, Bull-Engelstad I, Benth JŠ, Aasebø W, von der Lippe N, Reier-Nilsen M, Os I, Stavem K (2019)
   Effectiveness of using STOPP/START criteria to identify potentially inappropriate medication in people aged ≥ 65 years with chronic kidney disease: a randomized clinical trial
   Eur J Clin Pharmacol, 75 (11), 1503-1511
   DOI 10.1007/s00228-019-02727-9, PubMed 31359099
9. Parker K, Bull-Engelstad I, Aasebø W, von der Lippe N, Reier-Nilsen M, Os I, Stavem K (2019)
   Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease
   Hemodial Int, 23 (3), 333-342
   DOI 10.1111/hdi.12739, PubMed 30779285
10. Sommer M, von der Lippe N, Klow NE, Hoieggen A (2019)
    Renal fibromuscular dysplasia and hypertension
    Tidsskr. Nor. Laegeforen., 139 (4), 342-345
11. Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
    Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
    BMC Cardiovasc Disord, 19 (1), 4
    DOI 10.1186/s12872-018-0989-8, PubMed 30611196
12. Therkildsen J, Winther S, Nissen L, Jørgensen HS, Thygesen J, Ivarsen P, Frost L, Isaksen C, Langdahl BL, Hauge EM, Böttcher M (2019)
    Sex Differences in the Association Between Bone Mineral Density and Coronary Artery Disease in Patients Referred for Cardiac Computed Tomography
    J Clin Densitom, 24 (1), 55-66
    DOI 10.1016/j.jocd.2019.09.003, PubMed 31668962

Publications 2018

1. Kjeldsen SE, Os I, Nilsson PM (2018)
   Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?
   Hypertension, 72 (2), 291-293
   DOI 10.1161/HYPERTENSIONAHA.118.11455, PubMed 29967041
2. Kjeldsen SE, Stenehjem AE, Os I, van den Borne P (2018)
   European Society of Hypertension Scientific Newsletter: Update on Hypertension Management 2016; 17: Nr. 63* Treatment of High Blood Pressure in Elderly and Octogenarians
   J. Hyperton., 22 (2), 46-48
3. Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ (2018)
   Mortality due to bleeding, myocardial infarction and stroke in dialysis patients
   J Thromb Haemost, 16 (10), 1953-1963
   DOI 10.1111/jth.14254, PubMed 30063819
4. Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG (2018)
   Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study
   Nephrol Dial Transplant, 33 (1), 102-112
   DOI 10.1093/ndt/gfw360, PubMed 27798199

Publications 2017

1. Dupont L, Eide IA, Hartmann A, Christensen JH, Åsberg A, Jenssen T, Krarup H, Svensson M (2017)
   Haptoglobin 2-2 Genotype, Patient, and Graft Survival in Renal Transplant Recipients
   Prog Transplant, 27 (4), 386-391
   DOI 10.1177/1526924817732020, PubMed 29187131
2. Dupont L, Winther S, Jørgensen HS, Bomholt P, Bøtker HE, Bøttcher M, Ivarsen P, Svensson M (2017)
   Atrial function, atrial volume and cardiovascular clinical outcomes in patients with end-stage renal disease - A study of cardiac computed tomography
   J Cardiovasc Comput Tomogr, 11 (5), 389-396
   DOI 10.1016/j.jcct.2017.07.001, PubMed 28705554
3. Kjeldsen SE, Os I (2017)
   Interventions to improve adherence of antihypertensive medication in African-Americans
   J Hypertens, 35 (6), 1164-1165
   DOI 10.1097/HJH.0000000000001249, PubMed 28441256
4. Manner IW, Waldum-Grevbo B, Witczak BN, Bækken M, Øktedalen O, Os I, Schwartz T, Sjaastad I (2017)
   Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
   Blood Press, 26 (6), 332-340
   DOI 10.1080/08037051.2017.1346459, PubMed 28675304
5. Mariampillai JE, Eskås PA, Heimark S, Larstorp AC, Fadl Elmula FE, Høieggen A, Nortvedt P (2017)
   Apparent treatment-resistant hypertension - patient-physician relationship and ethical issues
   Blood Press, 26 (3), 133-138
   DOI 10.1080/08037051.2016.1277129, PubMed 28078909
6. Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
   Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
   Transpl Int, 30 (8), 827-840
   DOI 10.1111/tri.12973, PubMed 28436117
7. Rizvi SMH, Aagnes B, Holdaas H, Gude E, Boberg KM, Bjørtuft Ø, Helsing P, Leivestad T, Møller B, Gjersvik P (2017)
   Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study
   JAMA Dermatol, 153 (12), 1270-1277
   DOI 10.1001/jamadermatol.2017.2984, PubMed 29049612
8. Sagedal S, Sandvik L, Klingenberg O, Sandset PM (2017)
   β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane
   Scand J Clin Lab Invest, 77 (8), 679-684
   DOI 10.1080/00365513.2017.1397288, PubMed 29117741
9. Schei J, Stefansson VTN, Eriksen BO, Jenssen TG, Solbu MD, Wilsgaard T, Melsom T (2017)
   Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population
   Clin J Am Soc Nephrol, 12 (4), 624-634
   DOI 10.2215/CJN.09280916, PubMed 28153935
10. Stubnova V, Os I, Grundtvig M, Atar D, Waldum-Grevbo B (2017)
    Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
    Cardiorenal Med, 7 (2), 128-136
    DOI 10.1159/000454933, PubMed 28611786
11. van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ (2017)
    Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry
    Nephrol Dial Transplant, 32 (2), 348-355
    DOI 10.1093/ndt/gfw392, PubMed 28031344

Publications 2016

1. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
   Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
   Acta Anaesthesiol Scand, 60 (8), 1170-81
   DOI 10.1111/aas.12753, PubMed 27306254
2. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
   Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
   Crit Care, 20 (1), 314
   DOI 10.1186/s13054-016-1503-2, PubMed 27716377
3. Berra E, Azizi M, Capron A, Høieggen A, Rabbia F, Kjeldsen SE, Staessen JA, Wallemacq P, Persu A (2016)
   Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
   Hypertension, 68 (2), 297-306
   DOI 10.1161/HYPERTENSIONAHA.116.07464, PubMed 27296995
4. Brekke FB, Waldum-Grevbo B, von der Lippe N, Os I (2016)
   The effect of renal transplantation on quality of sleep in former dialysis patients
   Transpl Int, 30 (1), 49-56
   DOI 10.1111/tri.12866, PubMed 27696543
5. Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
   Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
   J Ren Nutr, 27 (3), 161-168
   DOI 10.1053/j.jrn.2016.09.008, PubMed 27838193
6. Eskas PA, Heimark S, Mariampillai JE, Larstorp ACK, Elmula FEMF, Hoieggen A (2016)
   Drug compliance and monitoring of antihypertensive treatment
   Tidsskr. Nor. Laegeforen., 136 (10), 920-923
7. Eskås PA, Heimark S, Eek Mariampillai J, Larstorp AC, Fadl Elmula FE, Høieggen A (2016)
   Adherence to medication and drug monitoring in apparent treatment-resistant hypertension
   Blood Press, 25 (4), 199-205
   DOI 10.3109/08037051.2015.1121706, PubMed 26729283
8. Heimark S, Eskås PA, Mariampillai JE, Larstorp AC, Høieggen A, Fadl Elmula FE (2016)
   Tertiary work-up of apparent treatment-resistant hypertension
   Blood Press, 25 (5), 312-8
   DOI 10.3109/08037051.2016.1172865, PubMed 27124769
9. Kjeldsen SE, Os I (2016)
   High blood pressure in US diabetic veterans with normal renal function: a plea for the design of a more powerful and conclusive outcome trial
   J Hypertens, 34 (5), 836-7
   DOI 10.1097/HJH.0000000000000896, PubMed 27027378
10. Kjeldsen SE, Os I (2016)
    Hypertension: When should we treat hypertension in patients with diabetes?
    Nat Rev Cardiol, 13 (5), 252-3
    DOI 10.1038/nrcardio.2016.49, PubMed 27053453
11. Kjeldsen SE, Os I, Redon J (2016)
    Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials
    J Hypertens, 34 (8), 1489-91
    DOI 10.1097/HJH.0000000000001002, PubMed 27355995
12. Kjeldsen SE, Stenehjem A, Os I, Van de Borne P, Burnier M, Narkiewicz K, Redon J, Agabiti Rosei E, Mancia G (2016)
    Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets
    Blood Press, 25 (6), 333-336
    DOI 10.1080/08037051.2016.1236329, PubMed 27644446
13. Kolseth IB, Reine TM, Parker K, Sudworth A, Witczak BJ, Jenssen TG, Kolset SO (2016)
    Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy
    J Diabetes Complications, 31 (1), 245-252
    DOI 10.1016/j.jdiacomp.2016.06.029, PubMed 27452162
14. Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
    Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
    BMC Nephrol, 17 (1), 148
    DOI 10.1186/s12882-016-0373-9, PubMed 27760523
15. Smedbråten J, Sagedal S, Åsberg A, Hartmann A, Rollag H, Mjøen G, Fagerland MW, Hansen SW, Mollnes TE, Thiel S (2016)
    Collectin Liver 1 and Collectin Kidney 1 of the Lectin Complement Pathway Are Associated With Mortality After Kidney Transplantation
    Am J Transplant, 17 (1), 265-271
    DOI 10.1111/ajt.13933, PubMed 27341702
16. Stubnova V, Os I, Grundtvig M, Waldum-Grevbo B (2016)
    Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients
    Cardiology, 134 (4), 413-22
    DOI 10.1159/000444658, PubMed 27120050
17. von der Lippe N, Waldum-Grevbo B, Varberg Reisæter A, Os I (2016)
    Is HRQOL in dialysis associated with patient survival or graft function after kidney transplantation?
    BMC Nephrol, 17, 94
    DOI 10.1186/s12882-016-0316-5, PubMed 27456506

Publications 2015

1. Amro A, Waldum-Grevbo B, von der Lippe N, Brekke FB, Miaskowski C, Os I (2015)
   Symptom Clusters From Dialysis to Renal Transplantation: A Five-Year Longitudinal Study
   J Pain Symptom Manage, 51 (3), 512-9
   DOI 10.1016/j.jpainsymman.2015.10.012, PubMed 26550937
2. Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
   Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
   Transplantation, 99 (8), 1730-7
   DOI 10.1097/TP.0000000000000660, PubMed 25757216
3. Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV (2015)
   One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
   Clin Transplant, 29 (3), 268-76
   DOI 10.1111/ctr.12515, PubMed 25644963
4. Kjeldsen SE, Fadl Elmula FE, Os I, Persu A, Jin Y, Staessen JA (2015)
   Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in patients with resistant hypertension to improve patients' adherence
   Eur Heart J Cardiovasc Pharmacother, 1 (1), 48-56
   DOI 10.1093/ehjcvp/pvu009, PubMed 27533966
5. Melsom T, Fuskevåg OM, Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO (2015)
   Estimated GFR is biased by non-traditional cardiovascular risk factors
   Am J Nephrol, 41 (1), 7-15
   DOI 10.1159/000371557, PubMed 25612475
6. Murbraech K, Massey R, Undset LH, Midtvedt K, Holdaas H, Aakhus S (2015)
   Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial
   Clin Transplant, 29 (8), 678-84
   DOI 10.1111/ctr.12565, PubMed 25982053
7. Opdal MS, Arnesen M, Müller LD, Hullstein I, Sayed K, Brørs O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
   Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
   Clin Ther, 37 (7), 1594-9
   DOI 10.1016/j.clinthera.2015.04.009, PubMed 25963997
8. Persu A, Jin Y, Fadl Elmula FE, Renkin J, Høieggen A, Kjeldsen SE, Staessen JA (2015)
   Renal denervation in treatment-resistant hypertension: a reappraisal
   Curr Opin Pharmacol, 21, 48-52
   DOI 10.1016/j.coph.2014.12.013, PubMed 25601357
9. Schei J, Stefansson VT, Mathisen UD, Eriksen BO, Solbu MD, Jenssen TG, Melsom T (2015)
   Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD
   Clin J Am Soc Nephrol, 11 (2), 280-6
   DOI 10.2215/CJN.07360715, PubMed 26668020
10. Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
    High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
    Blood Press, 24 (3), 131-8
    DOI 10.3109/21695717.2015.1030889, PubMed 25901999
11. Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
    Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
    J Hypertens, 33 (9), 1845-51; discussion 1852
    DOI 10.1097/HJH.0000000000000632, PubMed 26103130
12. Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
    High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
    Transplantation, 99 (4), 791-6
    DOI 10.1097/TP.0000000000000422, PubMed 25222012
13. Storhaug HM, Toft I, Norvik JV, Jenssen T, Eriksen BO, Melsom T, Løchen ML, Solbu MD (2015)
    Uric acid is associated with microalbuminuria and decreased glomerular filtration rate in the general population during 7 and 13 years of follow-up: The Tromsø Study
    BMC Nephrol, 16, 210
    DOI 10.1186/s12882-015-0207-1, PubMed 26651613
14. Waldum-Grevbo B (2015)
    What physicians need to know about renal function in outpatients with heart failure
    Cardiology, 131 (2), 130-8
    DOI 10.1159/000381012, PubMed 25966919
15. Waldum-Grevbo B, Leivestad T, Reisæter AV, Os I (2015)
    Impact of initial dialysis modality on mortality: a propensity-matched study
    BMC Nephrol, 16, 179
    DOI 10.1186/s12882-015-0175-5, PubMed 26519164

Publications 2014

1. Amro A, Waldum B, Dammen T, Miaskowski C, Os I (2014)
   Symptom clusters in patients on dialysis and their association with quality-of-life outcomes
   J Ren Care, 40 (1), 23-33
   DOI 10.1111/jorc.12051, PubMed 24438743
2. Amro A, Waldum B, von der Lippe N, Brekke FB, Dammen T, Miaskowski C, Os I (2014)
   Symptom clusters predict mortality among dialysis patients in Norway: a prospective observational cohort study
   J Pain Symptom Manage, 49 (1), 27-35
   DOI 10.1016/j.jpainsymman.2014.04.005, PubMed 24858738
3. Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
   Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
   Ann Rheum Dis, 74 (8), 1515-21
   DOI 10.1136/annrheumdis-2013-204804, PubMed 24695010
4. Bach-Gansmo T, Wien TN, Løndalen A, Halvorsen E (2014)
   Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake
   Clin Physiol Funct Imaging, 36 (3), 237-41
   DOI 10.1111/cpf.12219, PubMed 25524030
5. Beitland S, Os I, Sunde K (2014)
   Primary injuries and secondary organ failures in trauma patients with acute kidney injury treated with continuous renal replacement therapy
   Scientifica (Cairo), 2014, 235215
   DOI 10.1155/2014/235215, PubMed 25587490
6. Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
   Uric acid and clinical correlates of endothelial function in kidney transplant recipients
   Clin Transplant, 28 (10), 1167-76
   DOI 10.1111/ctr.12435, PubMed 25124959
7. Evenepoel P, Cooper K, Holdaas H, Messa P, Mourad G, Olgaard K, Rutkowski B, Schaefer H, Deng H, Torregrosa JV, Wuthrich RP, Yue S (2014)
   A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism
   Am J Transplant, 14 (11), 2545-55
   DOI 10.1111/ajt.12911, PubMed 25225081
8. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
   Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
   Hypertension, 63 (5), 991-9
   DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332
9. Frich J, Lundin KE, Os I (2014)
   [J. Frich and colleagues reply]
   Tidsskr Nor Laegeforen, 134 (5), 496; discussion 497
   DOI 10.4045/tidsskr.14.0202, PubMed 24621892
10. Holdaas H, Mjoen G (2014)
    Long-term risks of kidney donation: age known
    Am J Transplant, 14 (11), 2671-2
    DOI 10.1111/ajt.12971, PubMed 25293790
11. Kjeldsen SE, Os I (2014)
    Cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension and improving patients' adherence
    J Hypertens, 32 (12), 2357-8
    DOI 10.1097/HJH.0000000000000385, PubMed 25376250
12. Kjeldsen SE, Sørensen H, Fadl Elmula FE, Brekke M, Gjønnæss E, Hjørnholm U, Kjære VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Re: Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (15), 1449-50
    DOI 10.4045/tidsskr.14.0931, PubMed 25138398
13. Manner IW, Baekken M, Oektedalen O, Kvale D, Nowak P, Nielsen SD, Os I, Trøseid M (2014)
    Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
    J Acquir Immune Defic Syndr, 65 (4), e158-61
    DOI 10.1097/QAI.0000000000000055, PubMed 24577189
14. Mjøen G, Holdaas H (2014)
    Selecting appropriate controls for kidney donors
    Am J Transplant, 15 (1), 286
    DOI 10.1111/ajt.13016, PubMed 25363214
15. Murbraech K, Holdaas H, Massey R, Undset LH, Aakhus S (2014)
    Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients: an echocardiographic substudy of the randomized controlled CENTRAL trial
    Transplantation, 97 (2), 184-8
    DOI 10.1097/TP.0b013e3182a92728, PubMed 24092385
16. Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
    Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
    J Acquir Immune Defic Syndr, 67 (4), 370-4
    DOI 10.1097/QAI.0000000000000339, PubMed 25226210
17. Persu A, Fadl Elmula FEM, Jin Y, Os I, Kjeldsen SE, Staessen JA (2014)
    Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence
    Eur Cardiol, 9 (2), 110-114
    DOI 10.15420/ecr.2014.9.2.110, PubMed 30310496
18. Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (1), 32-6
    DOI 10.4045/tidsskr.13.0276, PubMed 24429753
19. Trøseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD (2014)
    Microbial translocation and cardiometabolic risk factors in HIV infection
    AIDS Res Hum Retroviruses, 30 (6), 514-22
    DOI 10.1089/aid.2013.0280, PubMed 24521167
20. von der Lippe N, Waldum B, Brekke FB, Amro AA, Reisæter AV, Os I (2014)
    From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life
    BMC Nephrol, 15, 191
    DOI 10.1186/1471-2369-15-191, PubMed 25465066
21. von der Lippe N, Waldum B, Østhus TB, Reisæter AV, Os I (2014)
    Health related quality of life in patients in dialysis after renal graft loss and effect of gender
    BMC Womens Health, 14 (1), 34
    DOI 10.1186/1472-6874-14-34, PubMed 24580724
22. Østevik L, Gunnes G, de Souza GA, Wien TN, Sørby R (2014)
    Nasal and ocular amyloidosis in a 15-year-old horse
    Acta Vet Scand, 56 (1), 50
    DOI 10.1186/s13028-014-0050-6, PubMed 25159190

Publications 2013

1. Brekke FB, Amro A, Hortemo Østhus TB, Dammen T, Waldum B, Os I (2013)
   Sleep complaints, depression and quality of life in Norwegian dialysis patients
   Clin Nephrol, 80 (2), 88-97
   DOI 10.5414/CN107916, PubMed 23611520
2. Brekke FB, Waldum B, Amro A, Østhus TB, Dammen T, Gudmundsdottir H, Os I (2013)
   Self-perceived quality of sleep and mortality in Norwegian dialysis patients
   Hemodial Int, 18 (1), 87-94
   DOI 10.1111/hdi.12066, PubMed 23841517
3. Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
   Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
   Clin Transplant, 28 (1), 134-40
   DOI 10.1111/ctr.12290, PubMed 24372653
4. Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
   Endothelial dysfunction is associated with graft loss in renal transplant recipients
   Transplantation, 95 (5), 733-9
   DOI 10.1097/TP.0b013e31827d6312, PubMed 23364481
5. Eriksen BO, Løchen ML, Arntzen KA, Bertelsen G, Eilertsen BA, von Hanno T, Herder M, Jenssen TG, Mathisen UD, Melsom T, Njølstad I, Solbu MD, Toft I, Mathiesen EB (2013)
   Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population
   Kidney Int, 86 (1), 146-53
   DOI 10.1038/ki.2013.470, PubMed 24304885
6. Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
   Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
   Hypertension, 62 (3), 526-32
   DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798
7. Kjeldsen SE, Os I, Mahfoud F (2013)
   Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects
   EuroIntervention, 9 Suppl R, R7-9
   DOI 10.4244/EIJV9SRA1, PubMed 23732159
8. Kjeldsen SE, Schultz M, Vinkenes K, Aksnes TA, Høieggen A (2013)
   [Blood Pressure Treatment--towards consensus on many things]
   Tidsskr Nor Laegeforen, 133 (21), 2226
   DOI 10.4045/tidsskr.13.1374, PubMed 24226313
9. Manner IW, Baekken M, Kvale D, Oektedalen O, Pedersen M, Nielsen SD, Nowak P, Os I, Trøseid M (2013)
   Markers of microbial translocation predict hypertension in HIV-infected individuals
   HIV Med, 14 (6), 354-61
   DOI 10.1111/hiv.12015, PubMed 23332095
10. Preljevic VT, Østhus TB, Os I, Sandvik L, Opjordsmoen S, Nordhus IH, Dammen T (2013)
    Anxiety and depressive disorders in dialysis patients: association to health-related quality of life and mortality
    Gen Hosp Psychiatry, 35 (6), 619-24
    DOI 10.1016/j.genhosppsych.2013.05.006, PubMed 23896282
11. Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
    The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
    Clin Transplant, 28 (1), 120-6
    DOI 10.1111/ctr.12288, PubMed 24351078
12. Storhaug HM, Norvik JV, Toft I, Eriksen BO, Løchen ML, Zykova S, Solbu M, White S, Chadban S, Jenssen T (2013)
    Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study
    BMC Cardiovasc Disord, 13, 115
    DOI 10.1186/1471-2261-13-115, PubMed 24330812
13. Waldum B, Os I (2013)
    The cardiorenal syndrome: what the cardiologist needs to know
    Cardiology, 126 (3), 175-86
    DOI 10.1159/000353261, PubMed 24022166

Publications 2012

1. Beitland S, Sunde K, Moen H, Os I (2012)
   Variability in Uremic Control during Continuous Venovenous Hemodiafiltration in Trauma Patients
   Crit Care Res Pract, 2012, 869237
   DOI 10.1155/2012/869237, PubMed 22666569
2. Brattelid T, Qvigstad E, Moltzau LR, Bekkevold SV, Sandnes DL, Birkeland JA, Skomedal T, Osnes JB, Sjaastad I, Levy FO (2012)
   The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure
   PLoS One, 7 (9), e45489
   DOI 10.1371/journal.pone.0045489, PubMed 23029047
3. Damås JK, Bækken M, Ueland T, Manner IW, Os I, Yndestad A, Flo TH, Øktedalen O, Aukrust P (2012)
   Serum levels of neutrophil gelatinase-associated lipocalin are associated with microalbuminuria in HIV-infected patients
   J Acquir Immune Defic Syndr, 59 (2), e24-5
   DOI 10.1097/QAI.0b013e31823f35a7, PubMed 22245717
4. Friberg AS, Lundgren T, Malm H, Felldin M, Nilsson B, Jenssen T, Kyllönen L, Tufveson G, Tibell A, Korsgren O (2012)
   Transplanted functional islet mass: donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients
   Transplantation, 93 (6), 632-8
   DOI 10.1097/TP.0b013e3182455912, PubMed 22258287
5. Fyhrquist F, Eriksson A, Saijonmaa O, Nordestgaard BG, Kontula K, de Faire U, Ibsen H, Kjeldsen S, Os I, Dahlöf B (2012)
   Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy
   J Renin Angiotensin Aldosterone Syst, 14 (3), 227-34
   DOI 10.1177/1470320312460292, PubMed 23077078
6. Gudmundsdottir H, Høieggen A, Stenehjem A, Waldum B, Os I (2012)
   Hypertension in women: latest findings and clinical implications
   Ther Adv Chronic Dis, 3 (3), 137-46
   DOI 10.1177/2040622312438935, PubMed 23251774
7. Høieggen A, Os I (2012)
   [Serious illness--tough treatment]
   Tidsskr Nor Laegeforen, 132 (14), 1624-5
   DOI 10.4045/tidsskr.12.0424, PubMed 22875129
8. Krämer BK, Klinger M, Vítko Š, Glyda M, Midtvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Ostrowski M, Senatorski G, Nordström J, Salmela K (2012)
   Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial
   Transplantation, 94 (5), 492-8
   DOI 10.1097/TP.0b013e31825c1d6c, PubMed 22858806
9. Manner IW, Baekken M, Oektedalen O, Os I (2012)
   Hypertension and antihypertensive treatment in HIV-infected individuals. A longitudinal cohort study
   Blood Press, 21 (5), 311-9
   DOI 10.3109/08037051.2012.680742, PubMed 22564000
10. Manner IW, Trøseid M, Oektedalen O, Baekken M, Os I (2012)
    Low nadir CD4 cell count predicts sustained hypertension in HIV-infected individuals
    J Clin Hypertens (Greenwich), 15 (2), 101-6
    DOI 10.1111/jch.12029, PubMed 23339727
11. Melsom T, Mathisen UD, Eilertsen BA, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO (2012)
    Physical exercise, fasting glucose, and renal hyperfiltration in the general population: the Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6)
    Clin J Am Soc Nephrol, 7 (11), 1801-10
    DOI 10.2215/CJN.02980312, PubMed 22917703
12. Nordstrand N, Hertel JK, Hofsø D, Sandbu R, Saltvedt E, Røislien J, Os I, Hjelmesaeth J (2012)
    A controlled clinical trial of the effect of gastric bypass surgery and intensive lifestyle intervention on nocturnal hypertension and the circadian blood pressure rhythm in patients with morbid obesity
    Surgery, 151 (5), 674-80
    DOI 10.1016/j.surg.2011.12.007, PubMed 22261295
13. Osthus TB, von der Lippe N, Ribu L, Rustøen T, Leivestad T, Dammen T, Os I (2012)
    Health-related quality of life and all-cause mortality in patients with diabetes on dialysis
    BMC Nephrol, 13, 78
    DOI 10.1186/1471-2369-13-78, PubMed 22863310
14. Smerud KT, Dolgos S, Olsen IC, Åsberg A, Sagedal S, Reisæter AV, Midtvedt K, Pfeffer P, Ueland T, Godang K, Bollerslev J, Hartmann A (2012)
    A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation
    Am J Transplant, 12 (12), 3316-25
    DOI 10.1111/j.1600-6143.2012.04233.x, PubMed 22946930
15. Waldum B, Stubnova V, Westheim AS, Omland T, Grundtvig M, Os I (2012)
    Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
    Clin Kidney J, 6 (1), 55-62
    DOI 10.1093/ckj/sfs174, PubMed 24422171
16. Waldum B, Westheim AS, Sandvik L, Flønæs B, Grundtvig M, Gullestad L, Hole T, Os I (2012)
    Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry
    J Am Coll Cardiol, 59 (4), 371-8
    DOI 10.1016/j.jacc.2011.10.864, PubMed 22261159
17. Østhus TB, Preljevic VT, Sandvik L, Leivestad T, Nordhus IH, Dammen T, Os I (2012)
    Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey
    Health Qual Life Outcomes, 10, 46
    DOI 10.1186/1477-7525-10-46, PubMed 22559816

Publications 2011

1. Campistol JM, de Fijter JW, Nashan B, Holdaas H, Vítko S, Legendre C (2011)
   Everolimus and long-term outcomes in renal transplantation
   Transplantation, 92 (3 Suppl), S3-26
   DOI 10.1097/TP.0b013e3182230900, PubMed 21799392
2. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
   Inflammation-associated graft loss in renal transplant recipients
   Nephrol Dial Transplant, 26 (11), 3756-61
   DOI 10.1093/ndt/gfr163, PubMed 21511816
3. Fyhrquist F, Silventoinen K, Saijonmaa O, Kontula K, Devereux RB, de Faire U, Os I, Dahlöf B (2011)
   Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study
   J Hum Hypertens, 25 (12), 711-8
   DOI 10.1038/jhh.2011.57, PubMed 21697896
4. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
   Rosuvastatin in diabetic hemodialysis patients
   J Am Soc Nephrol, 22 (7), 1335-41
   DOI 10.1681/ASN.2010090987, PubMed 21566054
5. Holdaas H, Rostaing L, Serón D, Cole E, Chapman J, Fellstrøm B, Strom EH, Jardine A, Midtvedt K, Machein U, Ulbricht B, Karpov A, O'Connell PJ, ASCERTAIN Investigators (2011)
   Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study
   Transplantation, 92 (4), 410-8
   DOI 10.1097/TP.0b013e318224c12d, PubMed 21697773
6. Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ (2011)
   Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children
   Scand J Trauma Resusc Emerg Med, 19, 44
   DOI 10.1186/1757-7241-19-44, PubMed 21798000
7. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO (2011)
   Impaired fasting glucose is associated with renal hyperfiltration in the general population
   Diabetes Care, 34 (7), 1546-51
   DOI 10.2337/dc11-0235, PubMed 21593291
8. Nordstrand N, Gjevestad E, Dinh KN, Hofsø D, Røislien J, Saltvedt E, Os I, Hjelmesæth J (2011)
   The relationship between various measures of obesity and arterial stiffness in morbidly obese patients
   BMC Cardiovasc Disord, 11, 7
   DOI 10.1186/1471-2261-11-7, PubMed 21284837
9. Os I, Gudmundsdottir H, Draganov B, von der Lippe E (2011)
   Sterile peritonitis associated with amino acid-containing dialysate--a single center experience in Norway
   Perit Dial Int, 31 (1), 103
   DOI 10.3747/pdi.2010.00298, PubMed 21282392
10. Preljevic VT, Østhus TB, Sandvik L, Bringager CB, Opjordsmoen S, Nordhus IH, Os I, Dammen T (2011)
    Psychiatric disorders, body mass index and C-reactive protein in dialysis patients
    Gen Hosp Psychiatry, 33 (5), 454-61
    DOI 10.1016/j.genhosppsych.2011.06.010, PubMed 21831445
11. Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
    A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
    Blood Purif, 32 (3), 151-5
    DOI 10.1159/000325227, PubMed 21659742
12. Strøm EH, Sund S, Reier-Nilsen M, Dørje C, Leren TP (2011)
    Lecithin: Cholesterol Acyltransferase (LCAT) Deficiency: renal lesions with early graft recurrence
    Ultrastruct Pathol, 35 (3), 139-45
    DOI 10.3109/01913123.2010.551578, PubMed 21323422
13. Østhus TB, Preljevic V, Sandvik L, Dammen T, Os I (2011)
    Renal transplant acceptance status, health-related quality of life and depression in dialysis patients
    J Ren Care, 38 (2), 98-106
    DOI 10.1111/j.1755-6686.2011.00254.x, PubMed 21917125

Publications 2010

1. Baekken M, Manner I, Ueland T, Frøland SS, Os I, Aukrust P, Oktedalen O, Damås JK (2010)
   Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients
   J Acquir Immune Defic Syndr, 53 (3), 419-20
   DOI 10.1097/QAI.0b013e3181ba4101, PubMed 20190590
2. Beitland S, Moen H, Os I (2010)
   Acute kidney injury with renal replacement therapy in trauma patients
   Acta Anaesthesiol Scand, 54 (7), 833-40
   DOI 10.1111/j.1399-6576.2010.02253.x, PubMed 20528778
3. Bryhni B, Arnesen E, Jenssen TG (2010)
   Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study
   BMC Endocr Disord, 10, 21
   DOI 10.1186/1472-6823-10-21, PubMed 21162746
4. Hedner T, Oparil S, Narkiewicz K, Os I (2010)
   Cardiovascular risks in HIV patients
   Blood Press, 19 (6), 325-7
   DOI 10.3109/08037051.2010.537016, PubMed 21080761
5. Manner IW, Baekken M, Oektedalen O, Sandvik L, Os I (2010)
   Effect of HIV duration on ambulatory blood pressure in HIV-infected individuals with high office blood pressure
   Blood Press, 19 (3), 188-95
   DOI 10.3109/08037051.2010.483055, PubMed 20482442
6. Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
   [Lupus-nephritis--diagnosis and treatment]
   Tidsskr Nor Laegeforen, 130 (11), 1140-4
   DOI 10.4045/tidsskr.09.0583, PubMed 20531500
7. Nordestgaard BG, Kontula K, Benn M, Dahlöf B, de Faire U, Edelman JM, Eliasson E, Fyhrquist F, Hille DA, Ibsen H, Lyle PA, Berg K, Sandberg M, Sethi AA, Wong PH, Os I (2010)
   Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study
   Pharmacogenet Genomics, 20 (2), 77-85
   DOI 10.1097/FPC.0b013e328333f70b, PubMed 20065889
8. Strøm EH, Reinholt FP, Midtvedt K (2010)
   JC virus-associated nephropathy: lack of convincing documentation of the diagnosis
   Transpl Infect Dis, 13 (1), 93-4
   DOI 10.1111/j.1399-3062.2010.00594.x, PubMed 21299773
9. Vervloet M, Bencova V, Malberti F, Ashman N, Os I, Saha H, Ureña P, Zitt E, Rix M, Ryba M, Fouque D, Dehmel B, Petavy F, Jacobson SH (2010)
   "Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study
   Clin Nephrol, 74 (3), 198-208
   DOI 10.5414/cnp74198, PubMed 20860904
10. Waldum B, Westheim AS, Sandvik L, Flønaes B, Grundtvig M, Gullestad L, Hole T, Os I (2010)
    Renal function in outpatients with chronic heart failure
    J Card Fail, 16 (5), 374-80
    DOI 10.1016/j.cardfail.2010.01.001, PubMed 20447572
11. Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Olsen MH, Ibsen H, Lindholm L, Dahlöf B, Devereux RB, Okin PM, Wachtell K (2010)
    Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study
    Am J Hypertens, 23 (8), 845-51
    DOI 10.1038/ajh.2010.89, PubMed 20431530
12. Østhus TB, Dammen T, Sandvik L, Bruun CM, Nordhus IH, Os I (2010)
    Health-related quality of life and depression in dialysis patients: associations with current smoking
    Scand J Urol Nephrol, 44 (1), 46-55
    DOI 10.3109/00365590903449324, PubMed 20030569

Publications 2009

1. Fellström B, Holdaas H, Jardine AG, Svensson MK, Gottlow M, Schmieder RE, Zannad F, AURORA Study Group (2009)
   Cardiovascular disease in patients with renal disease: the role of statins
   Curr Med Res Opin, 25 (1), 271-85
   DOI 10.1185/03007990802622064, PubMed 19210158
2. Gabrielli D, Krystal B, Katzarski K, Youssef M, Hachache T, Lopot F, Lasseur C, Gunne T, Draganov B, Wojke R, Gauly A (2009)
   Improved intradialytic stability during haemodialysis with blood volume-controlled ultrafiltration
   J Nephrol, 22 (2), 232-40
   PubMed 19384841
3. Gudmundsdottir H, Taarnhøj NC, Strand AH, Kjeldsen SE, Høieggen A, Os I (2009)
   Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men
   J Hum Hypertens, 24 (8), 505-13
   DOI 10.1038/jhh.2009.94, PubMed 20010619
4. Krämer BK, Klinger M, Wlodarczyk Z, Ostrowski M, Midvedt K, Stefoni S, Citterio F, Pietruck F, Squifflet JP, Segoloni G, Krüger B, Sperschneider H, Banas B, Bäckman L, Weber M, Carmellini M, Perner F, Claesson K, Marcinkowski W, Vítko S, Senatorski G, Salmela K, Nordström J (2009)
   Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results
   Clin Transplant, 24 (1), E1-9
   DOI 10.1111/j.1399-0012.2009.01162.x, PubMed 19925464
5. Manner I, Sagedal S, Røger M, Os I (2009)
   Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure
   Clin Nephrol, 72 (3), 224-8
   DOI 10.5414/cnp72224, PubMed 19761730
6. Solbu MD, Jenssen TG, Eriksen BO, Toft I (2009)
   Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study
   Metabolism, 58 (3), 408-15
   DOI 10.1016/j.metabol.2008.10.016, PubMed 19217459
7. Ureña P, Jacobson SH, Zitt E, Vervloet M, Malberti F, Ashman N, Leavey S, Rix M, Os I, Saha H, Ryba M, Bencova V, Baños A, Zani V, Fouque D (2009)
   Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study
   Nephrol Dial Transplant, 24 (9), 2852-9
   DOI 10.1093/ndt/gfp144, PubMed 19369690

Publications 2008

1. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population
   Nephrol Dial Transplant, 23 (10), 3130-7
   DOI 10.1093/ndt/gfn236, PubMed 18469311
2. Baekken M, Os I, Sandvik L, Oektedalen O (2008)
   Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy
   J Hypertens, 26 (11), 2126-33
   DOI 10.1097/HJH.0b013e32830ef5fb, PubMed 18854751
3. Baekken M, Os I, Stenehjem A, Sandvik L, Oektedalen O (2008)
   Association between HIV infection and attenuated diurnal blood pressure rhythm in untreated hypertensive individuals
   HIV Med, 10 (1), 44-52
   DOI 10.1111/j.1468-1293.2008.00655.x, PubMed 19018875
4. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008)
   Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
   Metabolism, 57 (10), 1422-7
   DOI 10.1016/j.metabol.2008.05.012, PubMed 18803948
5. Flaa A, Eide IK, Kjeldsen SE, Rostrup M (2008)
   Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study
   Hypertension, 52 (2), 336-41
   DOI 10.1161/HYPERTENSIONAHA.108.111625, PubMed 18574074
6. Gudmundsdottir H, Brørs O, Os I (2008)
   [Metformin should not be used by patients with reduced renal function]
   Tidsskr Nor Laegeforen, 128 (8), 936-7
   PubMed 18431417
7. Gudmundsdottir H, Strand AH, Høieggen A, Reims HM, Westheim AS, Eide IK, Kjeldsen SE, Os I (2008)
   Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men
   Blood Press, 17 (2), 94-103
   DOI 10.1080/08037050801972923, PubMed 18568698
8. Gudmundsdottir H, Strand AH, Kjeldsen SE, Høieggen A, Os I (2008)
   Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men
   J Clin Hypertens (Greenwich), 10 (11), 814-21
   DOI 10.1111/j.1751-7176.2008.00032.x, PubMed 19128269
9. Krogenaes AK, Taubøll E, Stien A, Oskam IC, Lyche JL, Dahl E, Thomassen RF, Sweeney T, Ropstad E (2008)
   Valproate affects reproductive endocrine function, testis diameter and some semen variables in non-epileptic adolescent goat bucks
   Theriogenology, 70 (1), 15-26
   DOI 10.1016/j.theriogenology.2008.01.029, PubMed 18394693
10. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T (2008)
    Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
    Nephrol Dial Transplant, 23 (9), 2818-26
    DOI 10.1093/ndt/gfn148, PubMed 18400822
11. Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators (2008)
    Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy
    Hypertension, 52 (1), 100-6
    DOI 10.1161/HYPERTENSIONAHA.108.110064, PubMed 18504323
12. Os I, Devereux RB, Okin PM (2008)
    Gender differences in left ventricular hypertrophy regression - Response
    Hypertension, 51 (6), E59
    DOI 10.1161/HYPERTENSIONAHA.108.113456
13. Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, Hille DA, Lyle PA, Okin PM, Dahlöf B, Oparil S (2008)
    Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study
    Hypertension, 51 (4), 1103-8
    DOI 10.1161/HYPERTENSIONAHA.107.105296, PubMed 18259029
14. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
    Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
    Nephrol Dial Transplant, 23 (12), 4054-60
    DOI 10.1093/ndt/gfn355, PubMed 18577532
15. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I (2008)
    Cardiovascular risk-factors predict progression of urinary albumin-excretion in a general, non-diabetic population: a gender-specific follow-up study
    Atherosclerosis, 201 (2), 398-406
    DOI 10.1016/j.atherosclerosis.2008.02.027, PubMed 18405901
16. Solbu MD, Kronborg J, Jenssen TG, Njølstad I, Løchen ML, Mathiesen EB, Wilsgaard T, Eriksen BO, Toft I (2008)
    Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events
    Atherosclerosis, 204 (2), 503-8
    DOI 10.1016/j.atherosclerosis.2008.11.002, PubMed 19091314
17. Strand A, Kjeldsen SE, Gudmundsdottir H, Os I, Smith G, Bjørnerheim R (2008)
    Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years
    Eur J Echocardiogr, 9 (1), 34-9
    DOI 10.1016/j.euje.2007.02.007, PubMed 17448731

Publications 2007

1. Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
   Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
   Metabolism, 56 (11), 1470-7
   DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096
2. Brattelid T, Tveit K, Birkeland JA, Sjaastad I, Qvigstad E, Krobert KA, Hussain RI, Skomedal T, Osnes JB, Levy FO (2007)
   Expression of mRNA encoding G protein-coupled receptors involved in congestive heart failure--a quantitative RT-PCR study and the question of normalisation
   Basic Res Cardiol, 102 (3), 198-208
   DOI 10.1007/s00395-007-0648-1, PubMed 17370034
3. Fellström B, Holdaas H, Jardine AG, Rose H, Schmieder R, Wilpshaar W, Zannad F, AURORA Study Group (2007)
   Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study
   Kidney Blood Press Res, 30 (5), 314-22
   DOI 10.1159/000106803, PubMed 17671394
4. Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS (2007)
   The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
   J Cardiovasc Pharmacol, 49 (1), 27-32
   DOI 10.1097/FJC.0b013e31802bdd8c, PubMed 17261960
5. Kjeldsen SE, Lyle PA, Kizer JR, Oparil S, Høieggen A, Os I (2007)
   Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
   Vasc Health Risk Manag, 3 (3), 299-305
   PubMed 17703637
6. Kronborg J, Jenssen T, Njølstad I, Toft I, Eriksen BO (2007)
   Metabolic risk factors associated with serum creatinine in a non-diabetic population
   Eur J Epidemiol, 22 (10), 707-13
   DOI 10.1007/s10654-007-9164-8, PubMed 17653600
7. Kronborg J, Johnsen SH, Njølstad I, Toft I, Eriksen BO, Jenssen T (2007)
   Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study
   Diabetologia, 50 (8), 1607-14
   DOI 10.1007/s00125-007-0715-z, PubMed 17558484
8. Midtvedt K, Bjorang O, Letting AS (2007)
   Successful pregnancy in renal transplant recipient with previous known polyomavirus nephropathy
   Clin Transplant, 21 (4), 571-3
   DOI 10.1111/j.1399-0012.2007.00673.x, PubMed 17645722
9. Nordal EJ, Os I (2007)
   [Uremic pruritus--pathogenesis and treatment]
   Tidsskr Nor Laegeforen, 127 (9), 1201-3
   PubMed 17479139
10. Singer JB, Holdaas H, Jardine AG, Fellstrøm B, Os I, Bermann G, Meyer JM, Assessment of Lescol in Renal Transplantation (ALERT) Study Investigators (2007)
    Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients
    J Lipid Res, 48 (9), 2072-8
    DOI 10.1194/jlr.M700076-JLR200, PubMed 17563401
11. Smebye ML, Iversen EK, Høieggen A, Flaa A, Os I, Kjeldsen SE, Olsen MH, Chattopadhyay A, Hille DA, Lyle PA, Devereux RB, Dahlöf B (2007)
    Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study)
    Am J Cardiol, 100 (5), 855-9
    DOI 10.1016/j.amjcard.2007.03.109, PubMed 17719333
12. Stenehjem AE, Bjørnerheim R, Os I (2007)
    From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion
    Blood Press, 16 (2), 87-94
    DOI 10.1080/08037050701287703, PubMed 17612906
13. Stenehjem AE, Vahter M, Nermell B, Aasen J, Lierhagen S, Mørland J, Jacobsen D (2007)
    Slow recovery from severe inorganic arsenic poisoning despite treatment with DMSA (2.3-dimercaptosuccinic acid)
    Clin Toxicol (Phila), 45 (4), 424-8
    DOI 10.1080/15563650701232489, PubMed 17486487
14. Strand A, Gudmundsdottir H, Høieggen A, Fossum E, Bjørnerheim R, Os I, Kjeldsen SE (2007)
    Increased hematocrit before blood pressure in men who develop hypertension over 20 years
    J Am Soc Hypertens, 1 (6), 400-6
    DOI 10.1016/j.jash.2007.07.002, PubMed 20409872
15. Strand AH, Gudmundsdottir H, Fossum E, Os I, Bjørnerheim R, Kjeldsen SE (2007)
    Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years
    J Clin Hypertens (Greenwich), 9 (5), 365-71
    DOI 10.1111/j.1524-6175.2007.06479.x, PubMed 17485972
16. Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I (2007)
    Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes
    Transplantation, 83 (5), 600-6
    DOI 10.1097/01.tp.0000255583.34329.dd, PubMed 17353781

Publications 2006

1. Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
   Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
   J Hum Hypertens, 20 (11), 860-6
   DOI 10.1038/sj.jhh.1002087, PubMed 16988754
2. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M (2006)
   Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges
   Hypertension, 47 (3), 396-402
   DOI 10.1161/01.HYP.0000203952.27988.79, PubMed 16446389
3. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Kjeldsen SE, Ibsen H, Wan Y, Julius S (2006)
   Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy
   J Clin Hypertens (Greenwich), 8 (3), 169-73
   DOI 10.1111/j.1524-6175.2006.04838.x, PubMed 16522993
4. Gudmundsdottir H, Aksnes H, Heldal K, Krogh A, Froyshov S, Rudberg N, Os I (2006)
   Metformin and antihypertensive therapy with drugs blocking the renin angiotensin system, a cause of concern?
   Clin Nephrol, 66 (5), 380-5
   DOI 10.5414/cnp66380, PubMed 17140168
5. Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
   [Staging and measurement of renal function in chronic renal conditions]
   Tidsskr Nor Laegeforen, 126 (9), 1198-200
   PubMed 16670740
6. Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A (2006)
   N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy
   Cardiology, 106 (2), 102-8
   DOI 10.1159/000092743, PubMed 16636540
7. Narayan P, Papademetriou V, Wachtell K, Gerdts E, Boman K, Nieminen MS, de Simone G, Dahlöf B, Fyhrquist F, Hoieggen A, Devereux RB (2006)
   Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study
   Hypertension, 47 (5), 868-73
   DOI 10.1161/01.HYP.0000215578.40687.6f, PubMed 16567586
8. Oien CM, Reisaeter AV, Os I, Jardine A, Fellström B, Holdaas H (2006)
   Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study
   Clin Transplant, 20 (3), 374-82
   DOI 10.1111/j.1399-0012.2006.00496.x, PubMed 16824157
9. Olsen GH, Andresen PA, Hilmarsen HT, Bjørang O, Scott H, Midtvedt K, Rinaldo CH (2006)
   Genetic variability in BK Virus regulatory regions in urine and kidney biopsies from renal-transplant patients
   J Med Virol, 78 (3), 384-93
   DOI 10.1002/jmv.20551, PubMed 16419108
10. Os I (2006)
    Comparison of doxazosin GITS and standard doxazosin in the treatment of high blood pressure
    Int J Clin Pharmacol Ther, 44 (3), 99-106
    DOI 10.5414/cpp44099, PubMed 16550731
11. Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S (2006)
    Treatment of isolated systolic hypertension in diabetes mellitus type 2
    Diabetes Obes Metab, 8 (4), 381-7
    DOI 10.1111/j.1463-1326.2005.00523.x, PubMed 16776744
12. Raeder H, Bjørkhaug L, Johansson S, Mangseth K, Sagen JV, Hunting A, Følling I, Johansen O, Bjørgaas M, Paus PN, Søvik O, Molven A, Njølstad PR (2006)
    A hepatocyte nuclear factor-4 alpha gene (HNF4A) P2 promoter haplotype linked with late-onset diabetes: studies of HNF4A variants in the Norwegian MODY registry
    Diabetes, 55 (6), 1899-903
    DOI 10.2337/db05-1677, PubMed 16731861
13. Reikvam A, Hexeberg S, Kvien TK, Slørdal L, Aabakken L, Engebretsen L, Flatø B, Idsø N, Johnsen V, Kalstad S, Madsen S, Mikkelsen K, Os I, REder J (2006)
    [Clinical use of COX inhibitors--a consensus]
    Tidsskr Nor Laegeforen, 126 (5), 591-5
    PubMed 16505867
14. Stenehjem AE, Gudmundsdottir H, Os I (2006)
    Office blood pressure measurements overestimate blood pressure control in renal transplant patients
    Blood Press Monit, 11 (3), 125-33
    DOI 10.1097/01.mbp.0000209080.24870.2d, PubMed 16702821
15. Stenehjem AE, Os I (2006)
    Clinical utility and applicability of smoothness index, normalized smoothness index and individualized RDH index during treatment of essential hypertension
    Blood Press, 15 (5), 281-90
    DOI 10.1080/08037050600996628, PubMed 17380846
16. Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjørnerheim R, Kjeldsen SE (2006)
    Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years
    J Hypertens, 24 (5), 905-13
    DOI 10.1097/01.hjh.0000222761.07477.7b, PubMed 16612253
17. Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
    No effect of increased water intake on blood viscosity and cardiovascular risk factors
    Br J Nutr, 96 (6), 993-6
    DOI 10.1017/bjn20061969, PubMed 17181872

Publications 2005

1. Eilertsen AL, Høibraaten E, Os I, Andersen TO, Sandvik L, Sandset PM (2005)
   The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis
   Maturitas, 52 (2), 111-8
   DOI 10.1016/j.maturitas.2005.01.004, PubMed 16186073
2. Fellström B, Zannad F, Schmieder R, Holdaas H, Jardine A, Rose H, Wilpshaar W, AURORA Study Group (2005)
   Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study
   Curr Control Trials Cardiovasc Med, 6 (1), 9
   DOI 10.1186/1468-6708-6-9, PubMed 15910680
3. Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D (2005)
   Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases
   Clin Nephrol, 64 (3), 190-7
   DOI 10.5414/cnp64190, PubMed 16175943
4. Høieggen A, Os I, Kjeldsen SE (2005)
   [Uric acid--more deleterious than we thought?]
   Tidsskr Nor Laegeforen, 125 (10), 1330-2
   PubMed 15909004
5. Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A (2005)
   A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients
   Cardiology, 103 (3), 148-55
   DOI 10.1159/000084584, PubMed 15785019
6. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG (2005)
   Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
   J Clin Endocrinol Metab, 91 (1), 145-53
   DOI 10.1210/jc.2005-1775, PubMed 16263815
7. Kjeldsen SE, Os I, Høieggen A, Beckey K, Gleim GW, Oparil S (2005)
   Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide
   Am J Cardiovasc Drugs, 5 (1), 17-22
   DOI 10.2165/00129784-200505010-00003, PubMed 15631534
8. Kjeldsen SE, Westheim AS, Os I (2005)
   Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE
   Curr Hypertens Rep, 7 (3), 155-7
   DOI 10.1007/s11906-005-0001-8, PubMed 15913486
9. Kjeldsen SE, Westheim AS, Os I (2005)
   More heat to support aggressive blood pressure lowering: the FEVER study
   J Hypertens, 23 (12), 2145-6
   DOI 10.1097/01.hjh.0000194123.27475.25, PubMed 16269953
10. Olsen MH, Fossum E, Høieggen A, Wachtell K, Hjerkinn E, Nesbitt SD, Andersen UB, Phillips RA, Gaboury CL, Ibsen H, Kjeldsen SE, Julius S (2005)
    Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy
    J Hypertens, 23 (4), 891-8
    DOI 10.1097/01.hjh.0000163160.60234.15, PubMed 15775796
11. Prøsch LK, Saelen MG, Gudmundsdottir H, Dyrbekk D, Hunderi OH, Arnesen E, Paulsen D, Skjønsberg H, Os I (2005)
    Blood pressure control is hard to achieve in patients with chronic renal failure: results from a survey of renal units in Norway
    Scand J Urol Nephrol, 39 (3), 242-8
    DOI 10.1080/00365590510007810-1, PubMed 16127803
12. Qvigstad E, Brattelid T, Sjaastad I, Andressen KW, Krobert KA, Birkeland JA, Sejersted OM, Kaumann AJ, Skomedal T, Osnes JB, Levy FO (2005)
    Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure
    Cardiovasc Res, 65 (4), 869-78
    DOI 10.1016/j.cardiores.2004.11.017, PubMed 15721867
13. Qvigstad E, Sjaastad I, Brattelid T, Nunn C, Swift F, Birkeland JA, Krobert KA, Andersen GØ, Sejersted OM, Osnes JB, Levy FO, Skomedal T (2005)
    Dual serotonergic regulation of ventricular contractile force through 5-HT2A and 5-HT4 receptors induced in the acute failing heart
    Circ Res, 97 (3), 268-76
    DOI 10.1161/01.RES.0000176970.22603.8d, PubMed 16002744
14. Reims HM, Sevre K, Fossum E, Mellem H, Eide IK, Kjeldsen SE (2005)
    Adrenaline during mental stress in relation to fitness, metabolic risk factors and cardiovascular responses in young men
    Blood Press, 14 (4), 217-26
    DOI 10.1080/08037050510034275, PubMed 16126555
15. Reims HM, Sevre K, Høieggen A, Fossum E, Eide I, Kjeldsen SE (2005)
    Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity
    Blood Press, 14 (3), 159-69
    DOI 10.1080/08037050510034176, PubMed 16036496
16. Saelen MG, Prøsch LK, Gudmundsdottir H, Dyrbekk D, Helge Hunderi O, Arnesen E, Paulsen D, Skjønsberg H, Os I (2005)
    Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function
    Blood Press, 14 (3), 170-6
    DOI 10.1080/08037050510008959, PubMed 16036497
17. Schiøtz Thorud HM, Stranda A, Birkeland JA, Lunde PK, Sjaastad I, Kolset SO, Sejersted OM, Iversen PO (2005)
    Enhanced matrix metalloproteinase activity in skeletal muscles of rats with congestive heart failure
    Am J Physiol Regul Integr Comp Physiol, 289 (2), R389-R394
    DOI 10.1152/ajpregu.00067.2005, PubMed 15802562
18. Sjaastad I, Birkeland JA, Ferrier G, Howlett S, Skomedal T, Bjørnerheim R, Wasserstrom JA, Sejersted OM (2005)
    Defective excitation-contraction coupling in hearts of rats with congestive heart failure
    Acta Physiol Scand, 184 (1), 45-58
    DOI 10.1111/j.1365-201X.2005.01431.x, PubMed 15847643
19. Tomson J, Os I, Lip GY (2005)
    Hormone replacement use and cardiovascular function and structure in postmenopausal women
    Blood Press, 14 (1), 3-5
    DOI 10.1080/08037050510008841, PubMed 15823940
20. Vítko S, Klinger M, Salmela K, Wlodarczyk Z, Tydèn G, Senatorski G, Ostrowski M, Fauchald P, Kokot F, Stefoni S, Perner F, Claesson K, Castagneto M, Heemann U, Carmellini M, Squifflet JP, Weber M, Segoloni G, Bäckman L, Sperschneider H, Krämer BK (2005)
    Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study
    Transplantation, 80 (12), 1734-41
    DOI 10.1097/01.tp.0000188300.26762.74, PubMed 16378069
21. Øien CM, Reisaeter AV, Leivestad T, Pfeffer P, Fauchald P, Os I (2005)
    Gender imbalance among donors in living kidney transplantation: the Norwegian experience
    Nephrol Dial Transplant, 20 (4), 783-9
    DOI 10.1093/ndt/gfh696, PubMed 15701672

Publications 2004

1. Fossum E, Høieggen A, Reims HM, Moan A, Rostrup M, Eide I, Kjeldsen SE (2004)
   High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men
   Blood Press, 13 (2), 89-94
   DOI 10.1080/08037050310031008, PubMed 15182111
2. Fossum E, Olsen MH, Høieggen A, Wachtell K, Reims HM, Ibsen H, Julius S, Kjeldsen SE (2004)
   Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy
   J Hum Hypertens, 18 (6), 375-80
   DOI 10.1038/sj.jhh.1001712, PubMed 15057253
3. Høieggen A, Alderman MH, Kjeldsen SE, Julius S, Devereux RB, De Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Chen C, Dahlöf B, LIFE Study Group (2004)
   The impact of serum uric acid on cardiovascular outcomes in the LIFE study
   Kidney Int, 65 (3), 1041-9
   DOI 10.1111/j.1523-1755.2004.00484.x, PubMed 14871425
4. Kjeldsen SE, Os I, Hedner T, Himmelmann A (2004)
   Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers
   Blood Press, 13 (6), 324-5
   DOI 10.1080/08037050410010416, PubMed 15771214
5. Os I, Oparil S, Gerdts E, Høieggen A (2004)
   Essential hypertension in women
   Blood Press, 13 (5), 272-8
   DOI 10.1080/08037050410024330, PubMed 15545149
6. Reims HM, Fossum E, Høieggen A, Moan A, Eide I, Kjeldsen SE (2004)
   Adrenal medullary overactivity in lean, borderline hypertensive young men
   Am J Hypertens, 17 (7), 611-8
   DOI 10.1016/j.amjhyper.2004.03.676, PubMed 15233980
7. Reims HM, Sevre K, Fossum E, Høieggen A, Eide I, Kjeldsen SE (2004)
   Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men
   Blood Press, 13 (5), 287-94
   DOI 10.1080/08037050410016474, PubMed 15545152
8. Reims HM, Sevre K, Fossum E, Høieggen A, Mellem H, Kjeldsen SE (2004)
   Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men
   J Hypertens, 22 (10), 2007-15
   DOI 10.1097/00004872-200410000-00025, PubMed 15361774
9. Stenehjem AE, Os I (2004)
   Reproducibility of blood pressure variability, white-coat effect and dipping pattern in untreated, uncomplicated and newly diagnosed essential hypertension
   Blood Press, 13 (4), 214-24
   DOI 10.1080/08037050410021432, PubMed 15581335